Skip to main content
Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model
Published Web Location
http://europepmc.org/articles/PMC4156393?pdf=renderNo data is associated with this publication.
Abstract
© 2014 Tradtrantip et al.Neuromyelitis optica (NMO) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to astrocytes causes complement-dependent cytotoxicity (CDC) and i
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.